ArticleBlood cancer journal2022

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.

Keli Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.